Press release
Peraso Inc. (NASDAQ: PRSO) Director Invests $127K, Ladenburg Thalmann Coverage, Gains Bullish Momentum
On Tuesday, June 11th, Peraso Inc. (NASDAQ: PRSO) Director Ian McWalter acquired 100,000 shares of the company's stock at an average price of $1.27 per share, totalling $127,000. This strategic investment increases McWalter's holdings to 101,246 shares.Image: https://www.abnewswire.com/uploads/9a500d398df4ec1d757968c73f802240.jpg
On June 12, 2024, Ladenburg Thalmann, a renowned Wall Street firm since 1876, initiated coverage [https://thestreetreports.com/wp-content/uploads/2024/06/PRSO-Updated-research.pdf] of Peraso Inc. (NASDAQ: PRSO). Research by Grandview Research in January 2024 highlighted the global mmWave market's growth to $3.75 billion in 2023. The study suggests that mmWave technology applications in consumer sectors could drive significant market expansion, potentially causing a paradigm shift and achieving a compound annual growth rate (CAGR) of around 40% through 2030. The mmWave technology market is expected to surpass $55 billion by the end of the decade, driven by the increasing use of bandwidth-intensive applications and the rising demand for high-speed IoT solutions. Founded in 2009, Peraso Inc. (NASDAQ: PRSO) has focused on mmWave solutions, establishing itself as the leading producer of mmWave devices and innovating high-volume mmWave production testing methodologies.
Ladenburg Thalmann states, "Considering the current size and anticipated rapid growth of the mmWave market, we believe Peraso's market-leading silicon and module solutions position the company for significant and sustained top- and bottom-line growth. We project a 22% revenue growth for 2024 and anticipate mmWave product revenue to increase by 160% year-over-year in 2025. With this expected growth, we value Peraso based on a multiple of 3x its estimated 2025 revenues, discounted back to the present at 20%. Therefore, we initiate coverage of Peraso Inc. (NASDAQ: PRSO) with a Buy rating and a 12-month price target of $3.75."
Peraso Inc. (NASDAQ: PRSO) shares opened at $1.50 on Friday. The stock has a twelve-month low of $1.17 and a 2024 high of $9.60, with a market cap of $4.01 million. It maintains a 50-day moving average of $1.37 and a 200-day moving average of $3.54. Recently, Peraso has shown multiple bullish indicators, reflected in a significant increase in trading volume over the past week, making it a stock to watch closely.
Pesaro Inc. NASDAQ: PRSO was recently featured with other MEME stocks trending tickers: GameStop (NYSE: GME). AMC Entertainment (NYSE: AMC), Novavax Inc. (NASDAQ: NVAX) Dyadic International Inc. (NASDAQ: DYAI), among others, [https://thestreetreports.com/meme-stocks-surge-led-by-roaring-kitty-and-social-media-buzz-on-reddit-nyse-rddt-gme-dyai-amc-prso-nvax/]
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.
Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=peraso-inc-nasdaq-prso-director-invests-127k-ladenburg-thalmann-coverage-gains-bullish-momentum]
Country: United States
Website: http://www.thestreetreports.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peraso Inc. (NASDAQ: PRSO) Director Invests $127K, Ladenburg Thalmann Coverage, Gains Bullish Momentum here
News-ID: 3545398 • Views: …
More Releases from ABNewswire
Migraine Therapeutic Pipeline Witnesses Significant Expansion as 30+ Pharma Comp …
DelveInsight's, "Migraine Pipeline Insight 2026" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Migraine pipeline landscape. It covers the Migraine pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Migraine Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Stay ahead in understanding the Migraine Treatment Landscape @ Migraine…
Obesity Clinical Trial Ecosystem Strengthens with 80+ Companies Driving Next-Gen …
DelveInsight's "Obesity Pipeline Insight 2026" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the obesity pipeline landscape. It covers the Obesity pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Obesity therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive Obesity pipeline products in this space.
Download DelveInsight's comprehensive Obesity Pipeline Report to explore emerging…
Chronic Kidney Disease Drug Development Pipeline Expands as 75+ Companies Focus …
DelveInsight's, "Chronic Kidney Disease Pipeline Insight 2026" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape. It covers the Chronic Kidney Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Chronic Kidney Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Multiple System Atrophy Clinical Pipeline Intensifies with 20+ Industry Players …
DelveInsight's "Multiple System Atrophy Pipeline Insight 2026" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Multiple System Atrophy pipeline landscape. It covers the Multiple System Atrophy Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Multiple System Atrophy Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious…
More Releases for Peraso
Undervalued Tech: Peraso Inc's (NASDAQ: PRSO) True Value Signals Upside - More S …
Mobix Labs recently made the kind of mistake that reveals more about the bidder than the target. Their unsolicited acquisition [https://www.stocktitan.net/news/PRSO/peraso-confirms-receipt-of-unsolicited-non-binding-acquisition-pevb9rjomb71.html] offer for Peraso represents classic bottom-feeding behavior. A 20% premium that exploits market pressure rather than recognizing strategic value.
This follows their established pattern of lowball offers to multiple companies. Mobix declined to sign standard confidentiality agreements, indicating they never intended serious due diligence. The timing reveals everything. PerasoInc's (NASDAQ:…
Peraso (NASDAQ: PRSO) Volume Surges on Takeover News - More Stocks Inside
Mobix Labs, Inc. (NASDAQ: MOBX) has launched an unsolicited, non-binding proposal to acquire Peraso Inc. (NASDAQ: PRSO) in a stock-for-stock deal offering Peraso shareholders a 20% premium over the company's 30-day average share price.
The proposed merger would create a stronger player in the high-growth mmWave, defense, and 5G semiconductor sectors-combining Mobix's $10.7M revenue base and ~450% YoY growth with Peraso's accelerating mmWave performance. The combined company is expected to generate…
Peraso (NASDAQ: PRSO) Powers Drone Tech Surge in Defense, eVTOL, Aerospace - Mor …
Peraso Inc. (NASDAQ: PRSO) is rapidly emerging as a dominant force in next-generation wireless communications, driven by its advanced mmWave connectivity solutions. Designed for drones and autonomous systems that demand real-time, low-latency data transfer, Peraso's technology is increasingly viewed as foundational to high-performance operations across the defense, aerospace, and mobility sectors.
As the electric aviation and eVTOL (electric vertical takeoff and landing) market gains traction in the U.S., Peraso's ultra-fast wireless…
Peraso Inc.'s (NASDAQ: PRSO) Beamforming Technology Gains Military Traction - Se …
Peraso Inc.'s (NASDAQ: PRSO) advanced beamforming technology has proven to be a game-changer in military and dense urban deployments, where secure, reliable, and high-performance communication is critical. Beamforming's ability to direct signals with precision and bend them around obstacles not only maximizes efficiency but also makes transmissions exceptionally difficult to detect or intercept. These stealth capabilities, combined with Peraso's proprietary innovations, have enabled its solutions to excel in active war…
Peraso Inc.'s (NASDAQ: PRSO) PERSPECTUS Modules Outperform in 60Ghz FWA Market
Introduction
As high-speed internet access spreads around the world, the unlicensed 60GHz (57-71 Ghz) millimeter-wave (mmWave) spectrum offers immense potential for low-cost, low-capex, easily-deployed high-speed wireless communication, especially areas currently underserved by traditional broadband distribution-fiberoptic. Further, However, until recently, purchasing devices to adequately provide mmWave communications for 60Ghz/mmWave broadband deployments has been difficult. Peraso and several other companies have developed and ramped up mass manufacturing of viable 60Ghz solutions for this…
Spotlight: Peraso Inc. (NASDAQ: PRSO) A Semiconductor Valued Stock In Focus
Peraso Inc. (NASDAQ: PRSO), a prominent player in mmWave technology for 5G licensed and 60 GHz unlicensed networks, disclosed its financial outcomes for the initial fiscal quarter concluding on March 31, 2024, on May 13. The company revealed total net earnings of $2.8 million, contrasting with $1.8 million in the preceding quarter and $5 million in the corresponding period of the prior year.
Image: https://www.abnewswire.com/uploads/ab52a2e3727e2c3a192fc9b4209229c4.jpg
During the first quarter, product revenues amounted…
